Arik Mizrachi, MD
Physical Medicine & Rehabilitation · Princeton, NJNPI 1871744367
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Johnson & Johnson at 36.9% of the total. Reporting peaked in 2019 at $140 and has fallen 82.2% since, to $25 in 2021. That places this record below the midpoint for physical medicine & rehabilitation clinicians in NJ, where the typical reported total is $187.
Across 12 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$87
- Pacira Therapeutics, Inc.$58
- Bioventus LLC$49
- Si-bone, Inc.$29
- Ferring Pharmaceuticals Inc.$13
What the payments were for
- Food & beverage$235100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $87 |
| Pacira Therapeutics, Inc. | 3 | $58 |
| Bioventus LLC | 2 | $49 |
| Si-bone, Inc. | 2 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
How this compares
$235 in reported general payments places this provider in the 50th percentile of 434 physical medicine & rehabilitation providers in New Jersey.
See all physical medicine & rehabilitation providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 519 | $2,625 |
| Etodolac | 137 | $2,345 |
| Meloxicam | 698 | $1,877 |
| Celecoxib | 107 | $1,830 |
| Tizanidine Hcl | 381 | $1,747 |
| Diclofenac Sodium | 146 | $825 |
| Cyclobenzaprine Hcl | 87 | $656 |
| Pregabalin | 75 | $652 |
| Nabumetone | 92 | $650 |
| Duloxetine Hcl | 36 | $492 |
| Diclofenac Potassium | 27 | $413 |
| Tramadol Hcl | 120 | $379 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $238 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 34 | $227 |
| Methylprednisolone | 27 | $167 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Princeton
- Steven EscaldiEdison$70K
- Yekyung KongWest Orange$61K
- Joseph IbrahimBayonne$50K
- Steven KirshblumWest Orange$47K
- Joseph ValenzaChester$29K
- Christine GreissEdison$28K
- Bianca MartinezManasquan$25K
- Jason SmithCedar Knolls$19K
- Sandeep RathiLakewood$14K
- Anand PooleriCamden$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.